Pear Therapeutics, Inc. - Class A Common Stock (NQ:PEAR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pear Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >

35 Stocks Moving In Wednesday's Mid-Day Session ↗

March 30, 2022

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales...

Via Benzinga

Where Pear Therapeutics Stands With Analysts ↗

March 29, 2022

Over the past 3 months, 4 analysts have published their opinion on Pear Therapeutics (NASDAQ:PEAR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...

Via Benzinga

Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

March 28, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Read Why BTIG Sees An Upside OF 55% In Pear Therapeutics ↗

January 03, 2022

BTIG

Via Benzinga

Earnings Scheduled For March 28, 2022 ↗

March 28, 2022

Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.

Via Benzinga

Pear Therapeutics Joins Epic App Orchard to Enable Clinicians to Monitor Prescription Digital Therapeutics

March 24, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics, SoftBank Team On Sleep/Wake Disorder Therapeutic For Japanese Market ↗

March 21, 2022

Pear Therapeutics Inc (NASDAQ: PEAR) has agreed with SoftBank Group Corp (OTC: SFTBY) to develop a Japanese-language digital therapeutic for sleep/wake disorders...

Via Benzinga

Pear Therapeutics Announces Agreement with SoftBank Corp. to Develop a Digital Therapeutic for Sleep/Wake Disorders for the Japanese Market

March 21, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics' Digital Therapeutic For Insomnia Shows Meaningful Reductions In Severity Through 6 Months ↗

March 15, 2022

Pear Therapeutics Inc (NASDAQ: PEAR) announced data that further underscore the effectiveness of Somryst for chronic insomnia at the World Sleep 2022.

Via Benzinga

Pear Therapeutics Announces Data from Two Studies Evaluating Prescription Digital Therapeutics (PDTs) for Chronic Insomnia Presented at World Sleep Congress 2022

March 15, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on March 28, 2022 at 4:30 p.m. Eastern Time

March 14, 2022

From Pear Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 07, 2022

Gainers TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 38.1% to $0.29 during Monday's regular session. As of 12:30 EST, TherapeuticsMD's stock is trading at a...

Via Benzinga

Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products

February 24, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics to Participate in Citi’s 2022 Virtual Healthcare Conference

February 17, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish

February 15, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics Announces State of Michigan to Fund Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders

February 10, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics to Participate in 9th Annual BTIG MedTech, Digital Health, Life Science & Diagnostics Conference

February 02, 2022

From Pear Therapeutics, Inc.

Via Business Wire

46 Stocks Moving In Thursday's Mid-Day Session ↗

January 27, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2022 ↗

January 26, 2022

Upgrades

Via Benzinga

Oklahoma Health Care Authority and Pear Therapeutics Enter into Value-Based Agreement for reSET® and reSET-O®

January 26, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022 ↗

January 20, 2022

Upgrades For W.P. Carey Inc (NYSE:WPC), B...

Via Benzinga

Pear Therapeutics Announces Operational Performance Metrics for Full Year 2021 and Reaffirms Financial and Operational Performance Metrics for Full Year 2022

January 18, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics to Further Support Point32Health Members in Recovery from Substance Use Disorders

January 13, 2022

From Pear Therapeutics, Inc.

Via Business Wire

45 Biggest Movers From Yesterday ↗

January 05, 2022

Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

January 04, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide ↗

January 03, 2022

Toward the end of trading Monday, the Dow traded up 0.43% to 36,496.18 while the NASDAQ rose 0.93% to 15,790.97. The S&P also rose, gaining 0.43% to 4,786.68. The U.S. has the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 03, 2022

Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million...

Via Benzinga

61 Biggest Movers From Yesterday ↗

January 04, 2022

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...

Via Benzinga

Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher ↗

January 03, 2022

Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99. The U.S. has the...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

January 03, 2022

Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.